))
Attorney Andrew M. Lieb
Manage episode 302999067 series 2893097
コンテンツは Dean Fanelli and Dr. Dean Fanelli によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dean Fanelli and Dr. Dean Fanelli またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
My guest today is Andrew M. Lieb - the Managing Attorney of Lieb at Law, P.C., with a practice focus on litigation and regulatory compliance. Mr. Lieb provides a wide range of legal services throughout the New York Metro area on such topics as real estate brokerage license law litigation / compliance, fair housing and discrimination litigation / compliance, employment disputes, residential and commercial landlord / tenant needs. Andrew also does discrimination prevention trainings for companies and discrimination litigation.
Other stories covered include:
72 percent of unvaccinated Americans would quit their job if vaccines are mandated https://thehill.com/changing-america/well-being/prevention-cures/571084-whopping-70-percent-of-unvaccinated-americans
Judge suspends NY state vaccine mandate for health care workers who claim religious exemption https://www.cnn.com/2021/09/14/us/new-york-covid-vaccine-mandate-lawsuit/index.html
Fauci says he would support vaccine requirements for air travel https://thehill.com/policy/healthcare/571902-fauci-says-he-would-support-vaccine-requirements-for-air-travelAbout Dr. Dean Fanelli
Dean Fanelli, Ph.D. is a patent, regulatory, and transactional attorney in the Washington, DC office of Cooley LLP (www.cooley.com) focusing on issues related to the development, protection, and commercialization of biotech and pharmaceutical products. In addition to Dr. Fanelli's expertise relating to legal issues involved in pharma and biotech development, Dr. Fanelli also understands the business needs of his clients as he has co-founded three biotechnology companies: PhosImmune, Inc. an immuno-oncology company, C-Reveal Therapeutics, LLC, an immuno-oncology drug development company focused on exposing tumors to immune responses and therapies, and most recently AexeRNA Therapeutics, LLC, an mRNA company developing advanced Lipid Nanoparticle delivery systems that reduce the side effects present in currently authorized mRNA COVID-19 vaccines. He is a regular on TV & Radio commenting on Covid-19 & Vaccines & also hosts his own podcast “Politics & Life Sciences Radio.”
51 つのエピソード
シェア
